Background
Temozolomide (trade name Temodar®) is an unwritten alkylating professional utilized for the coarse of action of refractory anaplastic astrocytoma -- a nature and severity of cancerous brain tumour. Temozolomide is the prodrug of MTIC (3-methyl-(triazen-One-yl)imidazole-Four-carboxamide).
Temodar is marketed by Schering Corporation, which as easily markets more well-known prescription like Clarinex, Nasonex, Levitra, Cipro, Vytorin, Diprolene, Elocon & Lotrisone.
Dosage Forms
Temozolomide is available inside the United States in 5mg, 20mg, 100mg, & 250mg capsules.
|